Northrop Grumman 10,000 Immunomes Project Establishes Initial Baseline for Healthy Immune System Using the publicly available ImmPort database, researchers standardized and analyzed immune-related data for more than 10,300 healthy individuals. Q&A: Sam Shekar Discusses Northrop Grumman's Plans for Genomics Market Premium Last month, during a forum organized by US News & World Report, Amy Caro, vice president of health IT programs at Northrop Northrop Grumman Gets $8.4M from USDHS to Field-Test PCR-Based Biothreat Detector Premium Northrop Grumman received the award under the BioWatch Gen-3 System Performance Demonstration Contract, and said that the contract could be worth up to $37 million over three years. Northrop Grumman Developing PCR-Based Biodefense Dx System Under $9.6M BARDA Contract Premium Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR. 3M, Northrop Grumman Get $15.8M to Develop MDx for Biological Weapons The firms won grants to develop integrated diagnostic systems used to counter natural or man-made biological threats. Mar 16, 2010 Luminex, Northrop Grumman Partner on Biodetection Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.